BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31675169)

  • 1. Factors Predictive of Radiographic Progression in Ankylosing Spondylitis.
    Sari I; Lee S; Tomlinson G; Johnson SR; Inman RD; Haroon N
    Arthritis Care Res (Hoboken); 2021 Feb; 73(2):275-281. PubMed ID: 31675169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor necrosis factor α inhibitors on spinal radiographic progression in patients with ankylosing spondylitis.
    Jeong H; Eun YH; Kim IY; Park EJ; Kim H; Lee J; Jeon CH; Koh EM; Cha HS
    Int J Rheum Dis; 2018 May; 21(5):1098-1105. PubMed ID: 29611287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis.
    Ajrawat P; Touma Z; Sari I; Taheri C; Diaz Martinez JP; Haroon N
    Int J Rheum Dis; 2020 Jun; 23(6):728-743. PubMed ID: 32419337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry.
    Popova V; Kissling S; Micheroli R; Bräm R; de Hooge M; Baraliakos X; Nissen MJ; Möller B; Exer P; Andor M; Distler O; Scherer A; Ospelt C; Ciurea A
    Arthritis Res Ther; 2023 Mar; 25(1):40. PubMed ID: 36915202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
    Molnar C; Scherer A; Baraliakos X; de Hooge M; Micheroli R; Exer P; Kissling RO; Tamborrini G; Wildi LM; Nissen MJ; Zufferey P; Bernhard J; Weber U; Landewé RBM; van der Heijde D; Ciurea A;
    Ann Rheum Dis; 2018 Jan; 77(1):63-69. PubMed ID: 28939631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
    Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
    Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data.
    Kim TJ; Shin JH; Sung IH; Lee S; Song Y; Kim TH
    Clin Exp Rheumatol; 2016; 34(4):668-72. PubMed ID: 27051061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients.
    Baraliakos X; Listing J; von der Recke A; Braun J
    J Rheumatol; 2009 May; 36(5):997-1002. PubMed ID: 19332632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low bone mineral density of vertebral lateral projections can predict spinal radiographic damage in patients with ankylosing spondylitis.
    Kim JW; Chung MK; Lee J; Kwok SK; Kim WU; Park SH; Ju JH
    Clin Rheumatol; 2019 Dec; 38(12):3567-3574. PubMed ID: 31402392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison.
    Braun J; Haibel H; de Hooge M; Landewé R; Rudwaleit M; Fox T; Readie A; Richards HB; Porter B; Martin R; Poddubnyy D; Sieper J; van der Heijde D
    Arthritis Res Ther; 2019 Jun; 21(1):142. PubMed ID: 31174584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
    van der Heijde D; Landewé R; Baraliakos X; Houben H; van Tubergen A; Williamson P; Xu W; Baker D; Goldstein N; Braun J;
    Arthritis Rheum; 2008 Oct; 58(10):3063-70. PubMed ID: 18821688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Necrosis Factor Inhibitors Reduce Spinal Radiographic Progression in Patients With Radiographic Axial Spondyloarthritis: A Longitudinal Analysis From the Alberta Prospective Cohort.
    Sepriano A; Ramiro S; Wichuk S; Chiowchanwisawakit P; Paschke J; van der Heijde D; Landewé R; Maksymowych WP
    Arthritis Rheumatol; 2021 Jul; 73(7):1211-1219. PubMed ID: 33538097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.
    Maas F; Spoorenberg A; Brouwer E; Bos R; Efde M; Chaudhry RN; Veeger NJ; van Ooijen PM; Wolf R; Bootsma H; van der Veer E; Arends S
    PLoS One; 2015; 10(4):e0122693. PubMed ID: 25879956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-alpha antibody infliximab.
    Baraliakos X; Listing J; Brandt J; Haibel H; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2007 Sep; 46(9):1450-3. PubMed ID: 17623745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial.
    Braun J; Baraliakos X; Hermann KG; Deodhar A; van der Heijde D; Inman R; Beutler A; Zhou Y; Xu S; Hsu B
    Ann Rheum Dis; 2014 Jun; 73(6):1107-13. PubMed ID: 23644549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels.
    Konsta M; Sakellariou GT; Rusman T; Sfikakis PP; Iliopoulos A; van der Horst-Bruinsma IE
    Joint Bone Spine; 2021 May; 88(3):105111. PubMed ID: 33278588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab.
    Baraliakos X; Listing J; Rudwaleit M; Brandt J; Sieper J; Braun J
    Ann Rheum Dis; 2005 Oct; 64(10):1462-6. PubMed ID: 15778240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
    Ramiro S; van Tubergen A; Stolwijk C; Landewé R; van de Bosch F; Dougados M; van der Heijde D
    Arthritis Res Ther; 2013 Jan; 15(1):R14. PubMed ID: 23327723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.
    Hebeisen M; Micheroli R; Scherer A; Baraliakos X; de Hooge M; van der Heijde D; Landewé R; Bürki K; Nissen MJ; Möller B; Zufferey P; Exer P; Ciurea A
    PLoS One; 2020; 15(3):e0230268. PubMed ID: 32196530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.
    Maas F; Arends S; Brouwer E; Essers I; van der Veer E; Efde M; van Ooijen PMA; Wolf R; Veeger NJGM; Bootsma H; Wink FR; Spoorenberg A
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1011-1019. PubMed ID: 27696754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.